Development of erythromycin loaded PLGA nanoparticles for improved drug efficacy and sustained release against bacterial infections and biofilm formation
Microbial Pathogenesis · 2024
DOI: 10.1016/j.micpath.2024.107083 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Pathogenesis, 2024. Verfasst von Kamal Mayattu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Nanobioscience Group, Agharkar Research Institute, GG Agarkar Road, Pune, 411004, India. Hauptthemen laut MEDLINE: Erythromycin, Biofilms, Polylactic Acid-Polyglycolic Acid Copolymer, Anti-Bacterial Agents. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 85 Literaturangaben. Gefördert von: Indian Council of Medical Research.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nanobioscience Group, Agharkar Research Institute, GG Agarkar Road, Pune, 411004, India.
- Nanobioscience Group, Agharkar Research Institute, GG Agarkar Road, Pune, 411004, India. Electronic address: vandanaghormade@aripune.org.
Förderung
- Indian Council of Medical Research
Zitieren
APA
Mayattu, K., Rajwade, J., & Ghormade, V. (2024). Development of erythromycin loaded PLGA nanoparticles for improved drug efficacy and sustained release against bacterial infections and biofilm formation. Microbial Pathogenesis. https://doi.org/10.1016/j.micpath.2024.107083
Vancouver
Mayattu K, Rajwade J, Ghormade V. Development of erythromycin loaded PLGA nanoparticles for improved drug efficacy and sustained release against bacterial infections and biofilm formation. Microbial Pathogenesis. 2024. doi:10.1016/j.micpath.2024.107083
BibTeX
@article{Mayattu2024,
author = {Mayattu, Kamal and Rajwade, Jyutika and Ghormade, Vandana},
title = {Development of erythromycin loaded PLGA nanoparticles for improved drug efficacy and sustained release against bacterial infections and biofilm formation},
journal = {Microbial Pathogenesis},
year = {2024},
doi = {10.1016/j.micpath.2024.107083}
}
EUVIMED